STOCK TITAN
  1. Home
  2. News
  3. 2023-06-10

Stock Market News 2023-06-10

10 news published.

2023-06-09 2023-06-11
IMPACT
SENTIMENT
06/10/2023 06:30 PM
OCUL : Nasdaq
Ocular Therapeutix™ Announces 12-Month Topline Data from Ongoing U.S.-Based Phase 1 Clinical Trial Evaluating OTX-TKI for Treatment of Wet AMD
clinical trial
IMPACT
SENTIMENT
06/10/2023 06:01 PM
PHVS : Nasdaq
Data of Deucrictibant for the On-Demand Treatment of HAE Attacks Presented at the EAACI Congress 2023
IMPACT
SENTIMENT
06/10/2023 12:00 PM
APTO : Nasdaq
Aptose Presents Highlights from Clinical Update
low float
IMPACT
SENTIMENT
06/10/2023 10:47 AM
NKTX : Nasdaq
Nkarta Presents NKX019 Clinical Data at the European Hematology Association 2023 Congress and 17th International Conference on Malignant Lymphoma
clinical trial
IMPACT
SENTIMENT
06/10/2023 10:45 AM
CLDX : Nasdaq
Celldex Therapeutics Presents Positive Data from Barzolvolimab Chronic Urticaria Program at EAACI 2023
IMPACT
SENTIMENT
06/10/2023 10:30 AM
GRCL : Nasdaq
Gracell Biotechnologies Presents Longer-Term Results for FasTCAR-T GC012F in B-Cell Non-Hodgkin’s Lymphoma at EHA2023, Highlighting 100% Overall Response Rate
IMPACT
SENTIMENT
06/10/2023 07:34 AM
BIOA : Nasdaq B : Nasdaq
FDA Advisory Committee votes unanimously to confirm clinical benefit of LEQEMBI® (lecanemab-irmb) for the treatment of early Alzheimer's disease
IMPACT
SENTIMENT
06/10/2023 07:00 AM
GOLD : NYSE
Barrick Paves the Way for Reintroduction of White Rhino to Garamba National Park
IMPACT
SENTIMENT
06/10/2023 05:00 AM
HOOK : Nasdaq
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
IMPACT
SENTIMENT
06/10/2023 01:00 AM
IPHA : Nasdaq
Innate Pharma Highlights Proprietary Tetra-specific ANKET® NK Cell Engager IPH6501 at the EHA 2023 Congress
2023-06-09 2023-06-11